Valuation : Stryker Corporation

Market Cap 13TCr 11TCr 10TCr 9.35TCr 18TCr 12,12300Cr 18TCr 1,21600Cr 47TCr 6,12000Cr 48TCr 47TCr 20,29200Cr P/E 2026 *
25.7x
P/E 2027 * 22.4x
Enterprise Value 14TCr 12TCr 11TCr 10TCr 19TCr 12,99500Cr 19TCr 1,30300Cr 51TCr 6,56000Cr 51TCr 50TCr 21,75100Cr EV / Sales 2026 *
4.98x
EV / Sales 2027 * 4.47x
Free-Float
94.9%
Yield 2026 *
1.09%
Yield 2027 * 1.16%
1 week-1.52%
Current month-0.71%
1 month-8.27%
3 months-3.40%
1 week 278.4
Extreme 278.4
284.1
1 month 278.4
Extreme 278.4
303.5
Manager TitleAgeSince
Chief Executive Officer 60 01/10/2012
President 49 01/01/2026
Director of Finance/CFO 50 01/04/2025
Director TitleAgeSince
Director/Board Member 82 01/01/1974
Director/Board Member 71 01/01/1984
Chairman 60 22/07/2014
Change 5-day change 1-year change 3-year change Capi.($)
-0.57%-1.52% - - 13TCr
+2.66%+0.38%-15.51%+15.17% 13TCr
-0.93%-0.65%-23.17%-1.07% 1.21TCr
-1.12%-2.72%+87.72%+137.58% 1.06TCr
+0.28%+1.87%-51.49%-70.20% 421.53Cr
-0.42%+2.19%-17.88%+50.05% 271.54Cr
-1.70%-0.78% - - 204.28Cr
+1.02%-1.48%-34.42%-74.14% 177.63Cr
-0.45%-2.20%-16.72%-17.14% 162.42Cr
Average -0.08%+0.03%-10.21%+5.75% 2.02TCr
Weighted average by Cap. +1.93%+0.15%-10.46%+19.08%

Financials

2026 *2027 *
Net sales 2.73TCr 2.35TCr 2.21TCr 2.01TCr 3.79TCr 2,60900Cr 3.8TCr 26TCr 10TCr 1,31700Cr 10TCr 10TCr 4,36600Cr 2.97TCr 2.56TCr 2.4TCr 2.19TCr 4.12TCr 2,83600Cr 4.14TCr 28TCr 11TCr 1,43200Cr 11TCr 11TCr 4,74700Cr
Net income 494.17Cr 425.83Cr 399.26Cr 364.46Cr 686.6Cr 47TCr 688.78Cr 4.74TCr 1.85TCr 24TCr 1.86TCr 1.82TCr 79TCr 574.62Cr 495.15Cr 464.25Cr 423.8Cr 798.37Cr 55TCr 800.91Cr 5.51TCr 2.15TCr 28TCr 2.16TCr 2.11TCr 92TCr
Net Debt 912.52Cr 786.32Cr 737.25Cr 673Cr 1.27TCr 87TCr 1.27TCr 8.75TCr 3.41TCr 44TCr 3.43TCr 3.35TCr 1,46000Cr 588.82Cr 507.39Cr 475.73Cr 434.27Cr 818.1Cr 56TCr 820.7Cr 5.64TCr 2.2TCr 28TCr 2.21TCr 2.16TCr 94TCr
Logo Stryker Corporation
Stryker Corporation is one of the world's leaders in designing, manufacturing and marketing medical equipment and devices in the fields of medical surgery, neurotechnology and orthopaedics. Net sales break down by family of products as follows: - surgical equipment and neurotechnology products (62.3%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipment, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (37.7%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2025, the group had 55 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (75.7%), Europe/Middle East/Africa (12.7%), Asia/Pacific (8.6%) and other (3%).
Employees
-
Date Price Change
28/26/28 €278.40 -0.57%
27/26/27 €280.00 0.00%
26/26/26 €280.00 0.00%
25/26/25 €280.00 -1.44%
24/26/24 €284.10 +0.50%
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
330.69USD
Average target price
382.72USD
Spread / Average Target
+15.73%

Quarterly revenue - Rate of surprise